Not for distribution to United States newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, in or into the United States.VANCOUVER,
TORONTO, ON / ACCESSWIRE / October 7, 2021 / GHP Noetic Science-Psychedelic Pharma Inc. (TSXV:PSYF.P) ("GHP"), a Capital Pool Company listed on the TSX Venture Exchange (the "Exchange"), is pleased to
/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental.